longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

INNOVITA's 7 respiratory antigen detection products have obtained medical device registration certification in Thailand

Zhitong
Feb 18, 2025 at 02:46 PM

Recently, the respiratory antigen 7-item testing product independently developed by INNOVITA successfully passed the medical device registration approval of the Thai Food and Drug Administration and was authorized for sale in the Thai market. The respiratory antigen 7-item testing product is an innovative in vitro diagnostic reagent that can simultaneously detect seven common pathogens, including influenza A virus, influenza B virus, respiratory syncytial virus, parainfluenza virus, adenovirus, and novel coronavirus. It features high efficiency, accuracy, and convenience, making it suitable for hospitals, laboratories, and grassroots health institutions

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

INNOVITA

INNOVITA

SH688253

-2.20%

InnoTek

InnoTek

SGM14

LongbridgeAI